Wells Fargo & Company »

Citius Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Citius Pharmaceuticals (CTXR) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Citius Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Citius Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $50 40 1.25

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Citius Pharmaceuticals

Vanguard Group
Geode Capital Management
Citadel Advisors
Susquehanna International
BlackRock
Northern Trust
UBS Group
Goss Wealth Management
State Street Corporation
Two Sigma Investments
Arkadios Wealth Advisors
Jane Street
XTX Topco
Cambridge Investment Research Advisors
Simplex Trading

View all funds holding Citius Pharmaceuticals